Treatment Patterns and Outcomes Associated With Palbociclib Plus Letrozole for Postmenopausal Women With HR+/HER2− Advanced Breast Cancer Enrolled in an Expanded Access Program
Author:
Funder
AbbVie
MedImmune
Novartis
Pfizer
Puma
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference12 articles.
1. Aromatase inhibitors in the treatment of breast cancer;Brodie;J Steroid Biochem Mol Biol,1994
2. Triple positive breast cancer: a distinct subtype?;Vici;Cancer Treat Rev,2015
3. ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2);Cardoso;Ann Oncol,2014
4. Optimal management of hormone receptor positive metastatic breast cancer in 2016;Reinert;Ther Adv Med Oncol,2015
5. FDA approval: palbociclib for the treatment of postmenopausal patients with estrogen receptor–positive, HER2-negative metastatic breast cancer;Beaver;Clin Cancer Res,2015
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Palbociclib Combined with an Aromatase Inhibitor in Patients with Breast Cancer with Lung or Liver Metastases in US Clinical Practice;Cancers;2023-11-02
2. Real‐world treatment patterns for palbociclib plus an aromatase inhibitor, or an aromatase inhibitor alone, for patients with metastatic breast cancer in the Flatiron Database;International Journal of Cancer;2023-10-13
3. Place in Therapy of Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: A Targeted Literature Review;Targeted Oncology;2023-04-19
4. Effect of prior treatments on post-CDK 4/6 inhibitor survival in hormone receptor-positive breast cancer;Breast Cancer Research and Treatment;2022-12-21
5. Palbociclib and letrozole in hormone-receptor positive advanced breast cancer: Predictive response and prognostic factors;Current Problems in Cancer;2022-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3